Abstract
This article highlights recent advances in the discovery of new positive allosteric modulators of the AMPA receptor, excluding compounds of thiadiazine chemotype, most of which were developed by Servier and the University of Liege. The field of AMPA receptor modulators continues to be a fertile area for the discovery of new potential therapeutic agents, and recent years have seen a marked diversification in the range of chemotypes prepared. An overview is also given of the recent key new biological data.
Keywords: AMPA receptor, AMPA positive modulator, thiadiazine chemotype, glutamatergic neurotransmitter system, neurodegenerative diseases, schizophrenia,Alzheimer's disease, Parkinson's disease, postsynaptic membrane, tetrameric complex, AMPAR complex, synaptic plasticity, glutamate bound dimer, benzothiadiazines, cornichon proteins, deactivation kinetics, cystine-knot AMPAR, cognitive performance, preclinical behavioural testing, chemotypes, trifluoromethylpyrazole, D-amphetamine-stimulated locomotion, Phenethyl Sulfonamide Series, aromatic thiophene linker, cell voltage-clamp electrophysiology, FLIPR-based assays, Cyclopropane Derivatives, FLUO-4, HEK293, indane core structure, Pyrrole/Thiophene Acid Series, Iminothiazole, Trifluoromethylpyrazole Series
Current Medicinal Chemistry
Title: Recent Advances in the Discovery of Selective AMPA Receptor Positive Allosteric Modulators
Volume: 17 Issue: 30
Author(s): Simon E. Ward and Mark Harries
Affiliation:
Keywords: AMPA receptor, AMPA positive modulator, thiadiazine chemotype, glutamatergic neurotransmitter system, neurodegenerative diseases, schizophrenia,Alzheimer's disease, Parkinson's disease, postsynaptic membrane, tetrameric complex, AMPAR complex, synaptic plasticity, glutamate bound dimer, benzothiadiazines, cornichon proteins, deactivation kinetics, cystine-knot AMPAR, cognitive performance, preclinical behavioural testing, chemotypes, trifluoromethylpyrazole, D-amphetamine-stimulated locomotion, Phenethyl Sulfonamide Series, aromatic thiophene linker, cell voltage-clamp electrophysiology, FLIPR-based assays, Cyclopropane Derivatives, FLUO-4, HEK293, indane core structure, Pyrrole/Thiophene Acid Series, Iminothiazole, Trifluoromethylpyrazole Series
Abstract: This article highlights recent advances in the discovery of new positive allosteric modulators of the AMPA receptor, excluding compounds of thiadiazine chemotype, most of which were developed by Servier and the University of Liege. The field of AMPA receptor modulators continues to be a fertile area for the discovery of new potential therapeutic agents, and recent years have seen a marked diversification in the range of chemotypes prepared. An overview is also given of the recent key new biological data.
Export Options
About this article
Cite this article as:
E. Ward Simon and Harries Mark, Recent Advances in the Discovery of Selective AMPA Receptor Positive Allosteric Modulators, Current Medicinal Chemistry 2010; 17 (30) . https://dx.doi.org/10.2174/092986710792927840
DOI https://dx.doi.org/10.2174/092986710792927840 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Review of Accelerator-Produced Ga-68 with Solid Targets
Current Radiopharmaceuticals Review and Analysis of thought Records: Creating a Coding System
Current Psychiatry Research and Reviews Monoclonal Antibodies in Rare Acquired Thrombotic Disorders: The Paradigms of Paroxysmal Nocturnal Hemoglobinuria, Thrombotic Thrombocytopenic Purpura and Central Retinal Vein Occlusion
Current Vascular Pharmacology Meal Replacement Beverage Twice a Day in Overweight and Obese Adults (MDRC2012-001)
Current Nutrition & Food Science IL-15 and HIV Infection: Lessons for Immunotherapy and Vaccination
Current HIV Research Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer’s Disease
Current Alzheimer Research Endothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia
Current Neuropharmacology The Use of Cell Products for Treatment of Autoimmune Neuroinflammatory Diseases
Current Medicinal Chemistry Editorial (Thematic Issue: Neuroglia in Alzheimer’s Disease: From Cohort to Contestant in the Disease Progression and its Therapy)
Current Alzheimer Research Detection of Amyloid-β Aggregates in Body Fluids: A Suitable Method for Early Diagnosis of Alzheimers Disease?
Current Alzheimer Research Patent Selections
Recent Patents on Anti-Infective Drug Discovery P2X7 Receptors: Channels, Pores and More
CNS & Neurological Disorders - Drug Targets Editorial: Advances in Therapies of Cerebellar Disorders
CNS & Neurological Disorders - Drug Targets Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations
Current Stem Cell Research & Therapy Treatment of Adolescent Substance Use Disorders and Co-Occurring Internalizing Disorders: A Critical Review and Proposed Model
Current Drug Abuse Reviews <i>Nothobranchius</i> Fish: An Untapped Resource for Studying Aging-Related Neurodegeneration
Current Aging Science Meet the Editorial Board
CNS & Neurological Disorders - Drug Targets Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice
Letters in Drug Design & Discovery Interactions Between Nanosized Materials and the Brain
Current Medicinal Chemistry New Insights on the Xenobiotic-Sensing Nuclear Receptors in Liver Diseases – CAR and PXR-
Current Drug Metabolism